Yazar "Yalcin, S." seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Determination of SARS-CoV-2 IgG antibody levels in hematology-oncology patients after COVID-19 vaccination(Verduci Publisher, 2024) Ozsoy, M.; Yalcin, S.; Varlibas, A.; Cifci, A.; Cesur, S.; Aksoy, A.; Berkem, R.OBJECTIVE: Cancer patients are among the high -risk groups where COVID-19 infection tends to be severe and can lead to increased mortality. Therefore, they are included in the priority groups for COVID-19 vaccination. This study aimed to compare the levels of SARS-CoV-2 immunoglobulin G (IgG) antibodies following two different COVID-19 vaccinations between hematology -oncology patients and healthcare personnel and to identify factors associated with these antibody levels. PATIENTS AND METHODS: A prospective study was conducted with 91 hematology -oncology patients (cancer group) and 75 healthcare personnel (control group) from January 2020 to June 2023. The cancer and control groups comprised adults who had received a booster dose, with either a single dose of BNT162b2 or two doses of CoronaVac' spaced one month apart, following their primary vaccination with two doses of either CoronaVac' or BNT162b2. Four weeks after the administration of the booster dose, levels of SARS-CoV-2 IgG antibodies were assessed using an ELISA kit. Antibody levels above 50 AU/mL were accepted as signifying seropositivity. RESULTS: The median SARS-CoV-2 IgG antibody level was lower in the cancer group compared to the control group (4,509 vs. 7,268, p = 0.004), while the rate of seroconversion was similar between the groups (97.8% vs. 100%, p = 0.564). In the cancer group, no association was found between SARS-CoV-2 IgG antibody levels and age, sex, comorbidity, type of malignancy, stage and duration, or type of vaccine. CONCLUSIONS: In cancer patients, the seroconversion positivity rate was about 98%. However, antibody responses were still lower compared to the control group. No difference was detected in antibody levels among cancer patients based on the type of vaccine.Öğe Effects of breeder age on mineral contents and weight of yolk sac, embryo development, and hatchability in Pekin ducks(Oxford Univ Press, 2014) Onbasilar, E. E.; Erdem, E.; Hacan, O.; Yalcin, S.The current study was carried out to investigate the effects of breeder age on egg composition, changes of embryo, yolk sac, and yolk minerals during incubation and hatchability in Pekin ducks. A total of 495 freshly laid eggs were obtained from the same flock of Pekin ducks, aged 28, 34, and 40 wk, and were reared in accordance with the management guide of the duck breeders (Star 53-Grimaud Freres). At each breeder age, egg measurements were made on a random subsample of unincubated eggs. Embryo and yolk sac measurements were made on embryonic day (E) 12, E16, E20, and E25. On d 28 of incubation, the healthy ducklings were removed and sex of chicks was determined. All chicks were weighed and hatching results were determined. Egg weight and yolk percentages increased; however, albumen percentages, shell thickness, and yolk index decreased as the flock aged. Shell percentages, shell breaking strength, albumen index, and haugh units were not affected by breeder age. Also, breeder age affected the Mg, P, K, Ca, Cu, and Zn levels in the yolk, except for Na level on day of setting, and breeder age affected the mineral consumed by embryo during incubation. However, on E25, the levels of examined minerals, except for P level in the yolk sac, were not statistically different in duck breeder age groups. Relative yolk sac and embryo weights of eggs obtained from different breeder ages varied from E16 to E25; however, embryo length was different in breeder age groups from E12 to E20. Hatching weight was affected by breeder age and sex. Hatching results were not different among breeder age groups. This study indicates that breeder age is important for some egg characteristics, relative yolk sac weight, some contents of minerals in the yolk, embryonic growth during incubation, and duckling weight.Öğe Effects of hen production cycle and egg weight on egg quality and composition, hatchability, duckling quality, and first-week body weight in Pekin ducks(Poultry Science Assoc Inc, 2011) OnbaSilar, E. E.; Erdem, E.; Poyraz, O.; Yalcin, S.This study was conducted to determine the effect of hen production cycle (HPC) and the effect of egg weight (EW) at the same egg production level on egg quality, egg composition, hatchability, duckling quality, and first-week BW in Pekin ducks. For HPC, hatching eggs were obtained from different Pekin-duck breeder flocks, aged 31 wk for the first production cycle (HPC1) and 78 wk for the second production cycle (HPC2). For EW, there were 3 categories: heavy (H), medium (M), and light (L). Ten eggs from each HPC and EW group were analyzed for the determination of egg quality, and albumen and yolk compositions. Ninety eggs from each HPC and EW group were incubated for the determination of hatchability, and duckling weight and quality. After quality scoring, 20 ducklings (10 male and 10 female) from each group were weighed, and reared to 1 wk of age in a brooder machine to determine relative growth (RG). The results showed that the albumen index; Haugh unit; shell percentage; yolk moisture, ash, protein, lipids, and triglycerides; albumen moisture, ash, and protein; yolk fatty acid contents; hatching weight; duckling weights at 1 wk of age; and RG were significantly affected by HPC. Egg weight affected shell thickness, yolk and albumen indices, Haugh unit, yolk and albumen percentages, yolk to albumen ratio, shell percentage, yolk fatty acid content, hatching weight, duckling weight at 1 wk of age, and RG.Öğe Investigation of the protective effect of erythropoietin against cisplatin-induced ovarian damage: a rat model(Oxford Univ Press, 2017) Sayan, C. Dayangan; Tulmac, O. Banu; Karaca, G.; Ozkan, Z. S.; Yalcin, S.; Devrim, T.; Badem, N. Dindar…Öğe Late effects of cutaneous 3-methylcholanthrene exposure on DNA damage-related pleiotropic growth factors and oxidative stress markers in mice(Comenius Univ, 2020) Devrim, T.; Ekici, H.; Devrim, A. K.; Sozmen, M.; Senol, A.; Bozkurt, K. M.; Yalcin, S.BACKGROUND: Skin is the body's first defence against direct exposure to variety of chemicals. Polycyclic aromatic hydrocarbons such as 3-methylcholanthrene (3-MC) are common in polluted urban air and have a potential of producing harmful effects. Moreover, their late effects can occur months or years after exposure. OBJECTIVES: We aimed to investigate the long-term effects of 3-MC induced dermal toxicity on the expression of markers of apoptosis, pleiotropic cytokines, and oxidative stress and to determine the protective effect of cisplatin. METHODS: Groups were designed as control (group 1), 3-MC applied (group 2) and 3-MC+cisplatin applied mice (group 3). Cutaneous expressions of TGF beta, PDGFA, PDGFC, bFGF, PDGFR alpha, USP28, and Ki67 were evaluated with qPCR. Total oxidant (TOS), total antioxidant (TAS) and oxidative stress index (OSI) values were determined in liver and kidney tissues. RESULTS: The expression levels of TGF beta, PDGFR alpha, USP-28, Ki67, and PDGFA were decreased significantly in MC applied groups. Renal TAS levels were significantly lower in group-3. Liver and kidney OSI values were increased in both groups 2 and 3. CONCLUSION: The results indicated that low dose 3-MC caused oxidative stress and downregulated apoptotic and cytokine markers in the long term and cisplatin had no ameliorative effects on this degeneration processes (Tab. 3, Fig. 3, Ref. 32).
